Strejczek, A.; Woszczyk, D.; Urbaniak, H.; Różańska, M.; Robak, M.; Matuszewska, Z.; Barciszewska, A.-M.
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery. Int. J. Mol. Sci. 2021, 22, 4925.
https://doi.org/10.3390/ijms22094925
AMA Style
Strejczek A, Woszczyk D, Urbaniak H, Różańska M, Robak M, Matuszewska Z, Barciszewska A-M.
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery. International Journal of Molecular Sciences. 2021; 22(9):4925.
https://doi.org/10.3390/ijms22094925
Chicago/Turabian Style
Strejczek, Agata, Dawid Woszczyk, Helena Urbaniak, Martyna Różańska, Michał Robak, Zofia Matuszewska, and Anna-Maria Barciszewska.
2021. "Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery" International Journal of Molecular Sciences 22, no. 9: 4925.
https://doi.org/10.3390/ijms22094925
APA Style
Strejczek, A., Woszczyk, D., Urbaniak, H., Różańska, M., Robak, M., Matuszewska, Z., & Barciszewska, A.-M.
(2021). Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery. International Journal of Molecular Sciences, 22(9), 4925.
https://doi.org/10.3390/ijms22094925